Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

LABCORP HOLDINGS INC. Director's Dealing 2022

Mar 31, 2022

30237_dirs_2022-03-31_b70e7f7f-ac21-4062-9bb3-ac9627361565.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LABORATORY CORP OF AMERICA HOLDINGS (LH)
CIK: 0000920148
Period of Report: 2022-03-29

Reporting Person: Schroeder Mark S (EVP, President-Diagnostics Lab)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2022-03-29 Common Stock S 2356 $277.11 Disposed 6605.4989 Direct

Footnotes

F1: Pursuant to a plan in accordance with Rule 10b5-1 under the Securities Exchange Act of 1934.